Objectives: In this study, we took advantage of nanotechnology to systematically investigate the antimicrobial activity of silver nanoparticles (AgNPs) against pathogenic microorganisms. This study aimed to synthesize AgNPs from Ralstonia sp. strain NS-7 and further characterization of synthesized AgNPs. Materials: The molecular characterization of isolated strain Ralstonia sp. NS-7 was done by 16S rRNA gene sequencing and the characterizations of synthesized AgNPs was achieved by UV-Visible spectroscopy, AFM, FTIR, HR-TEM, SEM, EDS and XRD. Later on, the efficacy of previously synthesized AgNPs was assessed in vitro against pathogens, such as Escherichia coli, Enterococcus faecalis, Streptococcus pneumoniae and Staphylococcus aureus. Finding: The UVvisible spectrophotometric observation of synthesized AgNPs showed maximum absorbance at 420 nm, the AFM data revealed the polydispersity of spherical nanoparticles. Further, the FTIR analysis expressed a unique IR spectral band patterning and the HR-TEM and SEM analysis showed the size of biosynthesized AgNPs in the range of 14.72 nm to 47.32 nm. The analysis of phylogenetic tree of the strain NS-7 revealed the most sequence similarity with Ralstonia sp. strain PGNP6. Finally, the AgNPs represented a broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria. Application: The biological method for the synthesis of AgNPs is eco-friendly, economical, green and non-toxic. Synthesized AgNPs from Ralstonia sp. strain NS-7 could be used as an alternative source of antimicrobial for the management of pathogenic and multi-drug resistant microorganisms.